GOLDMAN SACHS GROUP INC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 48 filers reported holding TRANSLATE BIO INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$28,368,000
+8.0%
1,030,039
-35.3%
0.01%
-14.3%
Q1 2021$26,261,000
+45.1%
1,592,511
+62.2%
0.01%
+40.0%
Q4 2020$18,097,000
-27.0%
981,921
-46.1%
0.01%
-28.6%
Q3 2020$24,775,000
+381.6%
1,820,327
+534.2%
0.01%
+250.0%
Q2 2020$5,144,000
+854.4%
287,015
+431.2%
0.00%
Q1 2020$539,000
+15.7%
54,031
-5.7%
0.00%
Q4 2019$466,000
+73.2%
57,321
+111.2%
0.00%
Q3 2019$269,000
-68.4%
27,136
-59.7%
0.00%
Q2 2019$850,000
+228.2%
67,332
+164.7%
0.00%
Q1 2019$259,000
+103.9%
25,435
+50.7%
0.00%
Q4 2018$127,000
-24.0%
16,874
+1.0%
0.00%
Q3 2018$167,000
-85.9%
16,701
-82.1%
0.00%
Q2 2018$1,183,00093,5000.00%
Other shareholders

There were no reported owners of TRANSLATE BIO INC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of TRANSLATE BIO INC shareholders